, Tracking Stock Market Picks
Enter Symbol:
Pluristem Therapeutics Inc. (PSTI) [hlAlert]

down 26.41 %

Pluristem Therapeutics Inc. (PSTI) rated Buy with price target $4 by Needham

Posted on: Tuesday,  Feb 3, 2015  8:25 AM ET by Needham

Needham rated Buy Pluristem Therapeutics Inc. (NASDAQ: PSTI) on 02/03/2015. Previously Needham rated Buy Pluristem Therapeutics Inc. (NASDAQ: PSTI) on 05/22/2012.,
when the stock price was $2.65. Since then, Pluristem Therapeutics Inc. has lost 26.42% as of 12/22/2015's recent price of $1.95.
If you would have followed the previous Needham's recommendation on PSTI, you would have lost 26.41% of your investment in 1309 days.

Pluristem Therapeutics Inc. is a bio-therapeutics company engaged in developing and intending to commercialize, cell therapy production technologies and products. The Company focuses on commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several degenerative, ischemic and autoimmune disorders. It is developing a pipeline of products, stored ready to use, that are derived from human placenta, a non-controversial, non-embryonic adult stromal cell source. The Company?s focuses in the development of product candidates for local administration for indications, such as Peripheral artery disease (PAD), Critical limb ischemia (CLI), intermittent claudication, neuropathic pain, wound healing and orthopedic injuries. The Company focuses on developing Placenta expanded cells- peripheral artery disease (PLX-PAD) cells as an allogeneic therapeutic product to treat CLI which results from PAD.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/3/2015 8:25 AM Buy
2.89 4.00
as of 8/27/2015
1 Week down  -9.30 %
1 Month down  -26.41 %
3 Months down  -27.50 %
1 YTD down  -44.60 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/22/2012 8:25 AM Buy
2.65 5.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy